An interventional study of Oat porridge and Whey protein isolate in Appetite and General Nutritional Disorders, sponsored by University of Westminster. Completed at 1 site in United Kingdom. Open to male participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-21.
Sponsored by University of Westminster · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 106 studies in Insulin Resistance with a site in United Kingdom — 7 open to participants now, 9 under way, none of them phase 3. Insulin Resistance · United Kingdom.
Among the 106 studies in Insulin Resistance with a site in United Kingdom, this one is the 74th largest by enrollment of the 95 interventional ones that give a count, is one of 2 that started in 2023, is one of 76 with no phase, and was the 103rd registered.
2,974 studies on the registry are indexed under Insulin Resistance; 336 are open to participants now.
Browse Insulin Resistance studies →7 of the 106 studies in Insulin Resistance with a site in United Kingdom are open now. Recruiting first, the newest first:
Cambridge University Hospitals NHS Foundation Trust · Sites in United Kingdom
Ages 18–85 · Healthy volunteers
Imperial College London · Sites in United Kingdom
Ages 18–70
Leeds Beckett University · Sites in United Kingdom
Ages 18–40
Manchester University NHS Foundation Trust · Sites in United Kingdom
Ages 18–99
Salah Snouda · Sites in United Kingdom
Ages 18+
A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →
Of the 241 Insulin Resistance studies recruiting now, 52 (22%) set no upper age limit and 157 (65%) stop at 75 or younger; 28 take children under 18; 112 take healthy volunteers.
This study: 18 Years to 50 Years · male · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
106 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 6 · Phase 2 3 · Phase 3 5 · Phase 4 6
First in 2002; this study’s year is marked. 2 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 12 is below the median of 40 across 2,371 interventional studies indexed under Insulin Resistance.
Median enrollment 31 across the 95 interventional studies, 147 across the 11 observational. Of the 83 that completed or were terminated, 17 (20%) have results posted.
This tab as a report to print or save as PDF → With an account.
12 of 106 have an industry lead sponsor. The 10 most frequent:
University of Westminster is the lead sponsor of 9 studies on the registry; 1 is open to participants now.
University of Westminster has 2 studies filed under Insulin Resistance — fewer than ten, so there is no comparison to draw.
4 of the studies in Insulin Resistance with a site in United Kingdom that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07606872Salah SnoudaValidation of the Snouda Metabolic Score for Phenotyping and Guiding Reversal in Type 2 Diabetes | 2026-12 |
| NCT06463483Imperial College LondonAutomated Insulin Delivery in Adults With Advanced Kidney Disease | 2026-12-30 |
| NCT07945093King's College LondonDiabetes Insulin Self-Management Education (DIME) Web-based Application to Support People With Type 2 Diabetes (T2D) Starting Insulin in Hospital | 2027-06-09 |
| NCT07073781Leeds Beckett UniversityProbiotics, Cognition and Metabolic Health in Young Adults With Overweight or Obesity | 2027-06-30 |
Add all 4 to your calendar (.ics) → With an account.
Among the 106 studies in Insulin Resistance with a site in United Kingdom, from their registry updates:
This tab as a report to print or save as PDF → With an account.
INTRODUCTION: Obesity is a global epidemic, with over 2.5 billion adults being classified as overweight and 890 million of these classified as obese. Overweight and obesity are the 5th cause of mortality globally, with an estimated 2.8 million related deaths among adults. The rising prevalence of obesity in adults is leading to a rise in the prevalence of type 2 diabetes, with an estimated 462 million individuals affected globally. At present, the most effective non-surgical obesity treatments offered by the National Health Service (NHS) are the subcutaneously administered GLP-1 receptor agonists. However, they may present potentially serious side effects following short-term use, and there are still uncertainties around long-term use side effects. Therefore, a dietary approach to weight loss or maintenance seems preferable.
Increasing protein intake is a commonly applied nutritional approach to appetite regulation. The increase in protein intake is often achieved by supplementation, using proteins isolated from dairy, such as whey and casein. However, with more individuals following plant-based diets over recent years, the interest in plant-based protein supplements has increased. While dairy-based proteins are well-characterised, the appetite regulatory characteristics of plant-based proteins have not yet been fully elucidated.
The main aim of this study is to investigate the effects of protein-enriched food items on appetite regulation compared to a standard carbohydrate-rich meal. Furthermore, this study will investigate whether there are any differences in appetite-related hormonal responses to a plant protein-containing meal replacement shake (containing rice and pea protein) or a potato protein-enriched standard carbohydrate-based meal compared to a whey protein-enriched standard carbohydrate-based meal.
Intervention study with four treatment groups in a randomised, single-blind, quadruple crossover design.
Healthy male participants (between the ages of 18 to 50 years) will receive four different isocaloric intervention meals with the same mass, on separate visit days, following a minimum of 8 hours overnight fast. The four meals will contain oat porridge prepared with coconut milk as a control, oat porridge prepared with coconut milk with added whey or potato protein isolates, and a complete meal replacement shake containing plant-based pea and rice proteins. The intervention meals will be followed by a standardised pasta-based ready meal after the 3-hour observation period. All participants will observe at least a two-day washout period between the differing treatments.
Biological samples (blood) will be collected at various times during the visit. Blood samples will be collected at baseline 0 min prior (T0), then at 30 min (T30), 60 min (T60), 120 min (T120) and 180 min (T180) after the intervention meal consumption.
In addition, pertinent questionnaires, Visual Analogue Scale [VAS] for assessing satiety and VAS for assessing intervention meals' perception and palatability will be collected. VAS for the assessment of satiety will be collected at T0, T30, T60, T120 and T180 and VAS assessing the perception and palatability of the intervention meals will be collected immediately following meal consumption.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Control Meal (9.5 g total protein)
Other: Oat porridge
(total protein 40.5 g; of which whey protein isolate contributed 34.2 g of protein)
Dietary Supplement: Whey protein isolate
(total protein 40.6 g; of which potato protein isolate contributed 34.39 g of protein)
Dietary Supplement: Potato protein isolate
(total protein 40 g, mostly from pea protein and brown rice protein isolates)
Dietary Supplement: Meal replacement shake
Oat flakes, 81g (equivalent to 9 g of protein), were presented to participants in the form of porridge, prepared with 500 mL coconut milk (equivalent to 0.5 g of protein) and 10 g of zero calorie sugar free syrup. The total energy content was equivalent to 400 Kcal. Participants were instructed to consume the entire meal presented to them in 15 minutes on an empty stomach when attending the study.
Whey protein isolate, 38g (equivalent to 34.2 g of protein), was presented to participants in the form of a porridge. Other ingredients in the whey protein enriched porridge: * Oat flakes 54 g (equivalent to 6 g of protein) * Coconut milk 300 mL (equivalent to 0.3 g of protein) * Water 150 mL * Zero calorie sugar free syrup 10 g The total energy content was equivalent to 401.74 Kcal. Participants were instructed to consume the entire meal presented to them in 15 minutes on an empty stomach when attending the study
Potato protein isolate, 38g (equivalent to 34.39 g of protein), was presented to participants in the form of a porridge. Other ingredients in the potato protein enriched porridge: * Oat flakes 54 g (equivalent to 6 g of protein) * Coconut milk 300 mL (equivalent to 0.3 g of protein) * Water 150 mL * Zero calorie sugar free syrup 10 g The total energy content equiv. 401.36 Kcal. Participants were instructed to consume the entire meal presented to them in 15 minutes on an empty stomach when attending the study.
A meal replacement, 90 g (equivalent to 40 g of total protein), was presented to participants in the form of a shake. Other ingredients in the meal replacement shake: \- Water 500 mL The total energy was equivalent to 400 Kcal Participants were instructed to consume the entire meal replacement shake presented to them in 15 minutes on an empty stomach when attending the study.
To assess the acute effects of oat porridge, whey protein isolate, potato protein isolate and meal replacement shake on glucose levels (T30)
Glucose (mmol/L)
Time frame: Glucose measured 30 minutes post meal consumption
To assess the acute effects of oat porridge, whey protein isolate, potato protein isolate, and meal replacement shake on glucose levels (T60)
Glucose (mmol/L)
Time frame: Glucose measured 60 minutes post meal consumption
To assess the acute effects of oat porridge, whey protein isolate, potato protein isolate, and meal replacement shake on glucose levels (T120)
Glucose (mmol/L)
Time frame: Glucose measured 120 minutes post meal consumption
To assess the acute effects of oat porridge, whey protein isolate, potato protein isolate, and meal replacement shake on glucose levels (T180)
Glucose (mmol/L)
Time frame: Glucose measured 180 minutes post meal consumption
To assess the acute effects of oat porridge, whey protein isolate, potato protein isolate, and meal replacement shake on insulin levels (T30)
Insulin (pmol/L)
Time frame: Insulin measured 30 minutes post meal consumption
To assess the acute effects of oat porridge, whey protein isolate, potato protein isolate, and meal replacement shake on insulin levels (T60)
Insulin (pmol/L)
Time frame: Insulin measured 160 minutes post meal consumption
To assess the acute effects of oat porridge, whey protein isolate, potato protein isolate, and meal replacement shake on insulin levels (T120)
Insulin (pmol/L)
Time frame: Insulin measured 120 minutes post meal consumption
To assess the acute effects of oat porridge, whey protein isolate, potato protein isolate, and meal replacement shake on insulin levels (T180)
Insulin (pmol/L)
Time frame: Insulin measured 180 minutes post meal consumption
To assess the acute effects of oat porridge, whey protein isolate, potato protein isolate, and meal replacement shake on glucagon-like peptide 1 levels (T30)
Glucagon-like peptide 1 (pmol/L)
Time frame: Glucagon-like peptide 1 measured 30 minutes post meal consumption
To assess the acute effects of oat porridge, whey protein isolate, potato protein isolate, and meal replacement shake on glucagon-like peptide 1 levels (T60)
Glucagon-like peptide 1 (pmol/L)
Time frame: Glucagon-like peptide 1 measured 60 minutes post meal consumption
To assess the acute effects of oat porridge, whey protein isolate, potato protein isolate, and meal replacement shake on glucagon-like peptide 1 levels (T120)
Glucagon-like peptide 1 (pmol/L)
Time frame: Glucagon-like peptide 1 measured 120 minutes post meal consumption
To assess the acute effects of oat porridge, whey protein isolate, potato protein isolate, and meal replacement shake on glucagon-like peptide 1 levels (T180)
Glucagon-like peptide 1 (pmol/L)
Time frame: Glucagon-like peptide 1 measured 180 minutes post meal consumption
To assess the acute effects of oat porridge, whey protein isolate, potato protein isolate, and meal replacement shake on gastric inhibitory polypeptide (T30)
Glucagon-like peptide 1 (pmol/L)
Time frame: Gastric inhibitory polypeptide measured 30 minutes post meal consumption
To assess the acute effects of oat porridge, whey protein isolate, potato protein isolate, and meal replacement shake on gastric inhibitory polypeptide (T60)
Glucagon-like peptide 1 (pmol/L)
Time frame: Gastric inhibitory polypeptide measured 60 minutes post meal consumption
To assess the acute effects of oat porridge, whey protein isolate, potato protein isolate, and meal replacement shake on gastric inhibitory polypeptide (T120)
Glucagon-like peptide 1 (pmol/L)
Time frame: Gastric inhibitory polypeptide measured 120 minutes post meal consumption
To assess the acute effects of oat porridge, whey protein isolate, potato protein isolate, and meal replacement shake on gastric inhibitory polypeptide (T180)
Glucagon-like peptide 1 (pmol/L)
Time frame: Gastric inhibitory polypeptide measured 180 minutes post meal consumption
To assess the acute effects of oat porridge, whey protein isolate, potato protein isolate, and meal replacement shake on peptide tyrosine tyrosine levels (T30)
Peptide tyrosine tyrosine (pmol/L)
Time frame: Peptide tyrosine tyrosine measured 30 minutes post meal consumption
To assess the acute effects of oat porridge, whey protein isolate, potato protein isolate, and meal replacement shake on peptide tyrosine tyrosine levels (T60) Markers: peptide tyrosine tyrosine (pmol/L)
Peptide tyrosine tyrosine (pmol/L)
Time frame: Peptide tyrosine tyrosine measured 60 minutes post meal consumption
To assess the acute effects of oat porridge, whey protein isolate, potato protein isolate, and meal replacement shake on peptide tyrosine tyrosine levels (T120)
Peptide tyrosine tyrosine (pmol/L)
Time frame: Peptide tyrosine tyrosine measured 120 minutes post meal consumption
To assess the acute effects of oat porridge, whey protein isolate, potato protein isolate, and meal replacement shake on peptide tyrosine tyrosine levels (T180)
Peptide tyrosine tyrosine (pmol/L)
Time frame: Peptide tyrosine tyrosine measured 180 minutes post meal consumption
To assess the acute effects of oat porridge, whey protein isolate, potato protein isolate, and meal replacement shake on ghrelin levels (T30)
Ghrelin (pmol/L)
Time frame: Ghrelin measured 30 minutes post meal consumption
To assess the acute effects of oat porridge, whey protein isolate, potato protein isolate, and meal replacement shake on ghrelin levels (T60)
Ghrelin (pmol/L)
Time frame: Ghrelin measured 60 minutes post meal consumption
To assess the acute effects of oat porridge, whey protein isolate, potato protein isolate, and meal replacement shake on ghrelin levels (T120)
Ghrelin (pmol/L)
Time frame: Ghrelin measured 120 minutes post meal consumption
To assess the acute effects of oat porridge, whey protein isolate, potato protein isolate, and meal replacement shake on ghrelin levels (T180)
Ghrelin (pmol/L)
Time frame: Ghrelin measured 180 minutes post meal consumption
To assess the acute effects of oat porridge, whey protein isolate, potato protein isolate, and meal replacement shake on appetite (T30)
Subjective analysis including: Visual Analogue Scale for Appetite (VAS-A). Scores range from 0 to 100 (the higher the score, the greater the level of appetite)
Time frame: Visual Analogue Scale for Appetite (VAS-A) collected 30 minutes after meal consumption
To assess the acute effects of oat porridge, whey protein isolate, potato protein isolate, and meal replacement shake on appetite (T60)
Subjective analysis including: Visual Analogue Scale for Appetite (VAS-A). Scores range from 0 to 100 (the higher the score, the greater the level of appetite)
Time frame: Visual Analogue Scale for Appetite (VAS-A) collected 60 minutes after meal consumption
To assess the acute effects of oat porridge, whey protein isolate, potato protein isolate, and meal replacement shake on appetite (T120)
Subjective analysis including: Visual Analogue Scale for Appetite (VAS-A). Scores range from 0 to 100 (the higher the score, the greater the level of appetite)
Time frame: Visual Analogue Scale for Appetite (VAS-A) collected 120 minutes after meal consumption
To assess the acute effects of oat porridge, whey protein isolate, potato protein isolate, and meal replacement shake on appetite (T180)
Subjective analysis including: Visual Analogue Scale for Appetite (VAS-A). Scores range from 0 to 100 (the higher the score, the greater the level of appetite)
Time frame: Visual Analogue Scale for Appetite (VAS-A) collected 180 minutes after meal consumption
To assess the perception of oat porridge, whey protein isolate, potato protein isolate, and meal replacement shake. Subjective analysis including Visual Analogue Scale for Perception and Palatability (VAS-P).
Scores range from 0 to 100 (the higher the score, the lower the palatability)
Time frame: VAS for Perception and Palatability collected immediately after meal consumption
To assess the effects of oat porridge, whey protein isolate, potato protein isolate, and meal replacement shake on food intake ad libitum, 3 hours after the intervention meal consumption.
Consecutive meal intake was assessed by measuring the weight in grams and calculating the energy content in Kcal of the food consumed.
Time frame: Ad libitum food intake was assessed 3 hours post breakfast intervention meal consumption
Plan to share: No
Ran from Jun 2023 to primary completion in Oct 2024, 16 months.
Of 715 non-industry interventional studies with no phase under Insulin Resistance, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's 16 months is below that.
Counting every sponsor, half of 755 studies reached it within 21 months; a quarter within 9 and three quarters within 40.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Whey Protein Isolate
University of Westminster